MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 207 filers reported holding MEDIVATION INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $3,168,000 | -89.6% | 38,918 | -92.3% | 0.03% | -90.2% |
Q2 2016 | $30,606,000 | +30.8% | 507,570 | -0.3% | 0.28% | +29.5% |
Q1 2016 | $23,407,000 | -21.4% | 509,072 | -17.4% | 0.22% | -21.4% |
Q4 2015 | $29,780,000 | -12.9% | 616,079 | -23.5% | 0.28% | -5.4% |
Q3 2015 | $34,208,000 | -82.3% | 804,912 | -52.5% | 0.30% | +2.4% |
Q2 2015 | $193,539,000 | -11.1% | 1,694,740 | +0.5% | 0.29% | -13.7% |
Q1 2015 | $217,696,000 | +27.9% | 1,686,657 | -1.3% | 0.34% | +21.8% |
Q4 2014 | $170,239,000 | -26.5% | 1,709,055 | -27.0% | 0.28% | -30.6% |
Q3 2014 | $231,583,000 | +22.2% | 2,342,299 | -4.7% | 0.40% | +28.2% |
Q2 2014 | $189,516,000 | +20.2% | 2,458,698 | +0.4% | 0.31% | +18.4% |
Q1 2014 | $157,673,000 | +780.2% | 2,449,494 | +772.7% | 0.26% | +770.0% |
Q4 2013 | $17,913,000 | -18.3% | 280,685 | -23.3% | 0.03% | -23.1% |
Q3 2013 | $21,930,000 | +45.2% | 365,876 | +19.2% | 0.04% | +30.0% |
Q2 2013 | $15,102,000 | – | 306,957 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 4,397,838 | $186,908,000 | 79.34% |
Redmile Group, LLC | 1,752,642 | $74,487,000 | 5.64% |
APIS CAPITAL ADVISORS, LLC | 93,500 | $3,974,000 | 5.50% |
March Altus Capital Management LP | 18,794 | $799,000 | 4.71% |
HealthCor Management, L.P. | 1,900,000 | $80,750,000 | 4.55% |
BB BIOTECH AG | 2,581,112 | $109,697,000 | 3.48% |
Selkirk Management LLC | 116,000 | $4,930,000 | 3.06% |
Opus Point Partners Management, LLC | 118,372 | $5,031,000 | 2.78% |
TORRAY INVESTMENT PARTNERS LLC | 797,015 | $33,873,000 | 2.49% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 3,772,600 | $160,336,000 | 1.78% |